X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - New Drug Approvals - 18/Jun 03:06

FDA Approves Skyrizi (risankizumab-rzaa) for Ulcerative Colitis

NORTH CHICAGO, Ill., June 18, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for adults with moderately to severely active ulcerative colitis, making...

Articles similaires

Sorry! Image not available at this time

AbbVie Announces Positive Topline Results from Phase 3 TEMPO-1 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

drugs.com - 26/Sep 00:09

NORTH CHICAGO, Ill., Sept. 26, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-1...

Sorry! Image not available at this time

FDA Approves Bimzelx for Three New Indications

drugs.com - 26/Sep 16:09

THURSDAY, Sept. 26, 2024 -- The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with active...

Sorry! Image not available at this time

FDA Approves Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

drugs.com - 27/Sep 04:09

PRINCETON, N.J.--(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

drugs.com - 27/Sep 04:09

PRINCETON, N.J.--(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

drugs.com - 01/Oct 22:48

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with...

Sorry! Image not available at this time

FDA approves isatuximab-irfc with bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma

oncologynews.com.au - 30/Sep 14:29

On September 20, 2024, the Food and Drug Administration approved isatuximab-irfc (Sarclisa, Sanofi-Aventis U.S. LLC) with bortezomib, lenalidomide,...

Sorry! Image not available at this time

FDA Approves Flyrcado (flurpiridaz F 18) Radioactive Diagnostic for Enhanced Diagnosis of Coronary Artery Disease

drugs.com - 27/Sep 20:09

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE) September 27, 2024 --GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

FDA Approves EBGLYSS Drug for Atopic Dermatitis in Adults and Children

medindia.net - 27/Sep 13:49

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients unresponsive to other...

Sorry! Image not available at this time

FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C

drugs.com - 25/Sep 07:09

AUSTIN, TX, September 25, 2024– IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative...

Sorry! Image not available at this time

FDA Approves First Flu Vaccine That Can Be Self-Administered at Home

drugs.com - 20/Sep 22:09

FRIDAY, Sept. 20, 2024 -- On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a...

Les derniers communiqués